Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,891,716
+$177,691 QoQ
Shares Held
19,261
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,629
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PDS Planning, Inc holds $51,175,189 across 14 Drug Manufacturers - General names. JNJ ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
108,761 | $27,368,618 | |
| 2 | LLY |
ELI LILLY & Co
|
7,599 | $9,114,469 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
19,261 | $4,891,716 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,830 | $2,291,155 | |
| 5 | NVS |
Novartis AG
|
9,632 | $1,509,527 | |
| 6 | AZN |
Astrazeneca PLC
|
6,926 | $1,313,308 | |
| 7 | AMGN |
Amgen Inc
|
3,399 | $1,230,845 | |
| 8 | PFE |
Pfizer Inc
|
31,747 | $764,467 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,891,716 | 19,261 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $4,714,025 | 19,285 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3,794,221 | 18,334 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,522,794 | 18,999 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,801,893 | 18,343 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $3,082,302 | 18,586 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,458,106 | 16,997 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,405,294 | 14,842 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,062,756 | 14,113 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,391,674 | 15,119 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,314,422 | 14,766 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,304,477 | 14,796 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,557,284 | 15,450 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,234,015 | 14,413 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,834,156 | 10,383 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,691,102 | 10,352 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,746,165 | 9,837 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,608,362 | 9,075 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,442,291 | 8,431 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $1,407,634 | 8,716 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $1,382,498 | 8,392 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,257,770 | 7,653 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,158,316 | 7,360 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $1,073,722 | 7,212 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $952,205 | 6,771 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $767,635 | 5,854 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||